UM
GWPH

Ulysses Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ulysses Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,700
Closed -$576K – 57
2014
Q1 		$576K Buy
+9,700
New +$577K 0.11% 52

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ulysses Management's GWPH Position: Q2 2014 in Review

Ulysses Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2014, closing a stake of 9,700 shares — an estimated $576K sold.

Ulysses Management first reported a position in GWPH in Q1 2014 and held it in 1 quarter. The position peaked at $576K in Q1 2014. 87 funds tracked by Wall St. Rank hold GWPH as of Q2 2014.

  • Ulysses Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2014 after selling out during the quarter.
  • Ulysses Management sold 9,700 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2014, an estimated $576K.
  • Ulysses Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 1 quarter.
  • Ulysses Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $576K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2014.

Based on Ulysses Management's 13F filing for Q2 2014, filed 14 Aug 2014.